Bluebird Bio Inc.

06/11/2021 | Press release | Distributed by Public on 06/11/2021 03:02

betibeglogene autotemcel (beti-cel) One-Time Gene Therapy for β-thalassemia Continues to Demonstrate Durable Efficacy Across Pediatric and Adult Patient Populations and All[...]